2024
Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations
Liu J, Borsari B, Li Y, Liu S, Gao Y, Xin X, Lou S, Jensen M, Garrido-MartÃn D, Verplaetse T, Ash G, Zhang J, Girgenti M, Roberts W, Gerstein M. Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations. Cell 2024, 188: 515-529.e15. PMID: 39706190, DOI: 10.1016/j.cell.2024.11.012.Peer-Reviewed Original ResearchGenome-wide association studiesCase-control genome-wide association studyMultivariate genome-wide association studyGenetic lociAssociation studiesGenetic dataGenetic associationPhenotypeGeneticsEnvironmental factorsDetection powerElfn1Adolescent Brain Cognitive DevelopmentLociGenesPsychiatric disordersADORA3Digital phenotyping
2023
Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex
Rompala G, Nagamatsu S, MartÃnez-Magaña J, Nuñez-RÃos D, Wang J, Girgenti M, Krystal J, Gelernter J, Hurd Y, Montalvo-Ortiz J. Profiling neuronal methylome and hydroxymethylome of opioid use disorder in the human orbitofrontal cortex. Nature Communications 2023, 14: 4544. PMID: 37507366, PMCID: PMC10382503, DOI: 10.1038/s41467-023-40285-y.Peer-Reviewed Original ResearchConceptsOpioid use disorderMulti-omics findingsGene expression patternsCo-methylation analysisGene expression profilesMulti-omics profilingGene networksDNA methylationNeuronal methylomesDNA hydroxymethylationMethylomic analysisExpression patternsExpression profilesEpigenetic disturbancesUse disordersPsychiatric traitsOrbitofrontal cortexOpioid-related drugsPostmortem orbitofrontal cortexEnvironmental factorsDrug interaction analysisOUD treatmentHuman orbitofrontal cortexOpioid signalingInteraction analysis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply